These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16445037)

  • 41. Controlled trial of different dosages of octreotide in the prevention of hyperamylasemia induced by endoscopic papillosphincterotomy.
    Testoni PA; Lella F; Bagnolo F; Buizza M; Colombo E
    Ital J Gastroenterol; 1994 Dec; 26(9):431-6. PubMed ID: 7541258
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The value of serum amylase and elastase measurements in the prediction of post-ERCP acute pancreatitis.
    Kapetanos D; Kokozidis G; Kinigopoulou P; Xiarchos P; Antonopoulos Z; Progia E; Kitis G
    Hepatogastroenterology; 2007 Mar; 54(74):556-60. PubMed ID: 17523321
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The mechanism of increased renal clearance of amylase in acute pancreatitis.
    Warshaw AL; Lee KH
    Gastroenterology; 1976 Sep; 71(3):388-91. PubMed ID: 950087
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of contrical introduced into Wirsung's duct on the morphofunctional response of the pancreas in acute experimental pancreatitis].
    Panchenkov RT; Penin VA; Kuznetsov EV
    Farmakol Toksikol; 1977; 40(3):333-6. PubMed ID: 302802
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of the somatostatin analogue octreotide on experimental pancreatitis in rats.
    Paran H; Klausner J; Siegal A; Graff E; Freund U; Kaplan O
    J Surg Res; 1996 May; 62(2):201-6. PubMed ID: 8632640
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Role octreotide in prevention of complications after pancreatoduodenal resections].
    Shatverian GA; Ratnikova NP; Mikhaĭlov IuE; Bedzhanian AL; Sidorov AN; Fisenko EP; Skipenko OG
    Khirurgiia (Mosk); 2004; (2):56-60. PubMed ID: 14997883
    [No Abstract]   [Full Text] [Related]  

  • 47. [Repetitive acute pancreatitis in a late-diagnosed cystic fibrosis: prevention of relapses by octreotide in the long term].
    Weber A; Queneau PE; Polio JC; Koch S; Fellmann F; Sauve G; Carayon P
    Gastroenterol Clin Biol; 2001 May; 25(5):546-8. PubMed ID: 11521109
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Efficacy of octreotide in the treatment of chyle fistulas associated with pancreatic disease].
    Zárate Moreno FA; Oms Bernad LM; Mato Ruiz R; Balaguer del Ojo C; Sala Pedrós J; Campillo Alonso F
    Cir Esp; 2013 Apr; 91(4):237-42. PubMed ID: 23228417
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of octreotide on polycystic liver volume.
    van Keimpema L; Drenth JP
    Liver Int; 2010 Apr; 30(4):633-4. PubMed ID: 19744163
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial.
    Li ZS; Pan X; Zhang WJ; Gong B; Zhi FC; Guo XG; Li PM; Fan ZN; Sun WS; Shen YZ; Ma SR; Xie WF; Chen MH; Li YQ
    Am J Gastroenterol; 2007 Jan; 102(1):46-51. PubMed ID: 17266687
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ftorafur therapy in acute pancreatitis.
    Hudvágner S; Gecser G; Tekeres M; Illényi L
    Acta Physiol Hung; 1984; 64(3-4):485-8. PubMed ID: 6085213
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute pancreatitis. Intra-arterial treatment with trasylol.
    Vestad E; Aakhus T
    Acta Chir Scand; 1970; 136(2):147-51. PubMed ID: 5314339
    [No Abstract]   [Full Text] [Related]  

  • 53. Prophylactic octreotide reduces the severity of histopathologic changes and hemodynamic shock in early taurodeoxycholate-induced experimental pancreatitis.
    Chen CC; Wang SS; Lee FY; Tsay SH; Wu SL; Lu RH; Chang FY; Lee SD
    Proc Natl Sci Counc Repub China B; 1999 Jan; 23(1):1-6. PubMed ID: 9949720
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The use of Octreotide-depo for the pancreatitis' prophylaxis after radical surgery of gastric cancer with lymphadenectomy].
    Chernousov AF; Egorov AV; Chernousov FA; Levkin VV; Vychuzhanin DV; Kharlov NS; Stepanov SN
    Khirurgiia (Mosk); 2012; (8):39-43. PubMed ID: 22968556
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Optimization of strategy of surgical treatment for acute destructive pancreatitis].
    Vinokurov MM; Ammosov VG; Ignat'ev VV
    Vestn Khir Im I I Grek; 2004; 163(3):68-70. PubMed ID: 15317167
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of octreotide administration on serum interleukin-6 (IL-6) levels of patients with acute edematous pancreatitis.
    Nikou GC; Giamarellos-Bourboulis EJ; Grecka P; Toumpanakis Ch; Giannikopoulos G; Katsilambros N
    Hepatogastroenterology; 2004; 51(56):599-602. PubMed ID: 15086213
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amylase isoenzyme clearances in normal subjects and in patients with acute pancreatitis.
    Long WB; Grider JR
    Gastroenterology; 1976 Oct; 71(4):589-93. PubMed ID: 955345
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Amylase test in the diagnosis of acute pancreatitis].
    Dehesa M; Segovia E
    Rev Gastroenterol Mex; 1979; 44(2):57-62. PubMed ID: 462067
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The hourly rate of urinary amylase excretion, serum amylase, and serum lipase. II. Patients with gastrointestinal and pancreatic disorders.
    Waller SL; Ralston AJ
    Gut; 1971 Nov; 12(11):884-90. PubMed ID: 5132218
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Initial experience with octreotide in the pediatric population.
    Lam JC; Aters S; Tobias JD
    Am J Ther; 2001; 8(6):409-15. PubMed ID: 11704779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.